Medtronic is a global healthcare technology company that develops and sells device-based therapies and related services across cardiovascular, neuroscience, medical surgical and diabetes markets. It operates internationally and is incorporated in Ireland.
The UK's £1.6bn national AI strategy targets healthcare breakthroughs from cancer detection to drug discovery. The AI healthcare market is forecast to reach US$696bn by 2034, a 38.5% CAGR.
FDA approved Medtronic's Hugo for urologic procedures; a new robotic and AR system showed high precision in jaw surgery; East and Central Africa saw its first robotic-assisted knee replacements.
New rankings from WIPR and IAM Patent 1000 recognize top US patent firms and lawyers, highlighting expertise in pharmaceutical litigation, tech disputes, and strategic portfolio management amid shifting PTAB procedures and rising NPE campaigns in life sciences.
MiniMed completed its $538 million IPO as its separation from Medtronic advances, with shares trading on the Nasdaq. Medtronic submitted the next-generation MiniMed Flex insulin pump to the FDA and reported a 14.8% year-over-year revenue increase for its Diabetes business. The full separation is expected to be complete by the end of calendar year 2026.
Medtronic reported interim Affera Sphere-9 data showing 65.5% of VT patients were free from recurrence at six months. The FDA granted Breakthrough Device designation for Sphere-9 and approved a U.S. pivotal IDE.
Healthcare stocks were described as a defensive sector facing 2026 reimbursement headwinds, while capex rankings showed HCA Healthcare, Johnson & Johnson and Merck at the top. The sources also highlighted how capex differs across providers, device makers and drug developers.
The FDA cleared MiniMed Flex, a screen-free insulin pump controlled by smartphone, and granted breakthrough device designation to Portal Diabetes’ implantable Portal Pump system. Portal Diabetes also began a Phase I study of Portal Insulin, while MiniMed said Flex supports its latest algorithm, sensors and infusion sets.
Intuitive Surgical disclosed that an unauthorized third party accessed internal IT business applications through a phishing incident, while Medtronic plans to lay off 81 employees from its Diabetes unit ahead of the MiniMed separation.
Medtronic's diabetes unit MiniMed is seeking up to $7.86 billion valuation in its U.S. IPO while cutting 81 jobs at its Northridge facility ahead of the planned separation into a standalone publicly traded company.
Medtronic announced FDA premarket approval for Infuse bone graft in transforaminal lumbar interbody fusion procedures at one or two levels from L2-S1, making it the only PMA-approved growth factor bone graft for ALIF, OLIF, and TLIF procedures.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07772258 |
Wearable-Supported Prehabilitation and Rehabilitation for Patients Undergoing Surgery for Pancreatic Cancer |
NOT_YET_RECRUITING | NA |
| NCT07769424 |
PACE Cognition Proof-of-Concept Study |
NOT_YET_RECRUITING | NA |
| NCT07754695 |
Measuring Normal Esophageal Flexibility in Children Using EndoFLIP |
NOT_YET_RECRUITING | |
| NCT07749326 |
Malignant Gastric Outlet Obstruction Study With Stomach Partitioning (GO-PART) |
RECRUITING | NA |
| NCT07748962 |
Decoding the Neural Mechanisms Underlying Postural Instability and Gait Dysfunction in Parkinson's Disease |
NOT_YET_RECRUITING | NA |
| NCT07731958 |
Unilateral vs. Bilateral Lung Volume Reduction Surgery |
RECRUITING | NA |
| NCT07721948 |
Assessment of Catheter Tissue Contact in PFA |
NOT_YET_RECRUITING | NA |
| NCT07644260 |
Transition From Sevoflurane to Total Intravenous Anesthesia in Pediatric Patients |
NOT_YET_RECRUITING | |
| NCT07632430 |
End-Tidal CO2 (ETCO2) Trends in Out-of-Hospital Cardiac Arrest |
ACTIVE_NOT_RECRUITING | |
| NCT07602036 |
Type 2 Diabetes and Pregnancy a Single-arm Interventional Study |
NOT_YET_RECRUITING | NA |
